Hepatic Fgf21 expression is increased in the patients with hepatic steatosis, in mouse models of obesity or nonalcoholic fatty liver disease, and in response to ER stress (Tezze et al., 2019). The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.